Clinical Trials Browser

Phase 1/2 × Myeloproliferative Disorder, Chronic, with Eosinophilia × 90 days × Clear all

Myeloproliferative Disorder, Chronic, with Eosinophilia, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant